Corrigendum: The predictive validity of a Brain Care Score for late-life depression and a composite outcome of dementia, stroke, and late-life depression: data from the UK Biobank cohort
Year: 2024
Type: erratum
Abstract: In the published article Dr. Westover’s disclosure statement was inadvertently omitted. The disclosure should read:"Dr. M. Brandon Westover has private equity as co-founder of Beacon Biosignals and receives compensation for consulting and scientific advisory roles. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.”The authors apologize for this omission and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Source: Frontiers in Psychiatry
Authors: Sanjula D. Singh, Cyprien A. Rivier, Keren Papier, Zeina Chemali, Leidys Gutierrez-Martinez, Livia Parodi, Ernst Mayerhofer, Jasper Senff, Santiago Clocchiatti-Tuozzo, Courtney Nunley, Amy Newhouse, An Ouyang, M. Brandon Westover, Rudolph E. Tanzi, Ronald M. Lazar, Aleksandra Pikula, Sarah Ibrahim, H. Bart Brouwers, Virginia J. Howard, George Howard, Nirupama Yechoor, Thomas Littlejohns, Kevin N. Sheth, Jonathan Rosand, Gregory Fricchione, Christopher D. Anderson, Guido J. Falcone
Institutions: Broad Institute, Massachusetts General Hospital, Massachusetts Institute of Technology, Yale University, University of Oxford, Brigham and Women's Hospital, University Medical Center Utrecht, University of Alabama at Birmingham, UAB Medicine, University of Toronto, Krembil Brain Institute, Toronto General Hospital, Toronto General Hospital Research Institute, Elisabeth-TweeSteden Ziekenhuis, Benson-Henry Institute
Language: English
Subfield: Psychiatry and Mental health
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,295
OpenAlex ID: W4404288288